-

Milliman analysis: Q2 2024 mortgage default risk increases slightly for GSE acquisitions

Home price appreciation continued to surpass 5% annually in Q2

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today announced the second quarter (Q2) 2024 results of the Milliman Mortgage Default Index (MMDI), which shows Milliman’s latest monthly estimate of the lifetime serious delinquency rates (180 days +) of U.S.-backed mortgages.

Mortgage delinquency risk increased to 2.13% for loans acquired in Q2 of 2024, compared to 2.09% for loans acquired during Q1 2024, driven primarily by the projected slowing of home price appreciation. Borrower risk for the quarter improved, with less-risky purchase loans continuing to make up the bulk of originations, at about 87% of total volume, compared to refinance loans, which are less attractive to buyers in this higher interest rate environment.

“Until interest rates decline, we’re likely to see refinance volume remain low – which strengthens underwriting and borrower risk in our index,” said Jonathan Glowacki, a principal at Milliman and co-author of the MMDI. “The increases we’re seeing in default rates are economic in nature, primarily driven by home price appreciation, which, while it remained strong in Q2, is projected to slow.”

The MMDI reflects a baseline forecast of future home prices. When reviewing quarter-over-quarter changes in the MMDI, it is important to note that the MMDI values for Q2 2024 have been restated since the last publication and adjusted due to actual home price appreciation exceeding forecasts. During Q2, home price appreciation surpassed 5%, and forecasts project home prices to grow at approximately 2% annually.

For more information, go to www.milliman.com/mmdi. To access additional mortgage market thought-leadership, analytics, and technology go to https://www.milliman.com/en/products/milliman-m-pire.

About Milliman

Milliman is among the world's largest providers of actuarial, risk management, and technology solutions. Our consulting and advanced analytics capabilities encompass healthcare, property & casualty insurance, life insurance and financial services, and employee benefits. Founded in 1947, Milliman is an independent firm with offices in major cities around the globe. Visit us at milliman.com.

Contacts

Johnathan Glowacki
Milliman, Inc.
Tel: +1 262 641 3560
Johnathan.Glowacki@milliman.com

Industry:

Milliman, Inc.

Release Summary
Milliman has just released the latest results of its Mortgage Default Index.
Release Versions
English

Contacts

Johnathan Glowacki
Milliman, Inc.
Tel: +1 262 641 3560
Johnathan.Glowacki@milliman.com

More News From Milliman, Inc.

Milliman analysis: Corporate pension funding levels rise for eighth consecutive month in November

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released its monthly Milliman 100 Pension Funding Index (PFI), which analyzes the 100 largest U.S. corporate pension plans. During November, the PFI funded ratio edged up from 107.0% at the end of October to 107.1% as of November 30. A 1-basis-point rise in discount rates, to 5.34% in November, drove this result. It shaved $3 billion from plan liabilities and offset market returns of only 0.44%. As o...

Milliman analysis: Public pension funding rises in October to highest level in study history

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released the latest results of its Public Pension Funding Index (PPFI), which analyzes data from the nation’s 100 largest public defined benefit plans. For the seventh straight month, the PPFI funded ratio improved in October, rising from 85.4% as of September 30 to 86.3% as of October 31, surpassing the previous high-water mark of 85.5% set at the end of 2021. Another month of strong investment retu...

Milliman CareFlowIQ Strengthens Real-Time Clinical Intelligence Platform with Expanded Medication History from Surescripts

SEATTLE--(BUSINESS WIRE)--Milliman CareFlowIQ™, transforming fragmented healthcare data into trusted, proven, evidence-based insights for informed decision-making, announces expanded medication reconciliation capabilities from Surescripts, the nation's leading health intelligence network. With Surescripts Medication History for Reconciliation, CareFlowIQ will give healthcare providers unprecedented access to comprehensive, real-time patient medication history. This data enhances whole-patient v...
Back to Newsroom